EXCLUSIVE: Zai Lab’s Samantha Du scoops up China rights to an autoimmune drug with a hefty $175M licensing deal — heavily fronted with cash and stock

Argenx $ARGX has just scored a major licensing pact with Samantha Du’s Zai Lab, and it includes some of the largest numbers in cash and …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

EX­CLU­SIVE: Zai Lab’s Saman­tha Du scoops up Chi­na rights to an au­toim­mune drug with a hefty $175M li­cens­ing deal — heav­i­ly front­ed with cash and stock